Hyperthermia uses heat of up to 113°F to damage or kill cancer cells without harming surrounding tissue. Clinical trials have shown significant improvement in outcomes when hyperthermia was added to radiation therapy and/or chemotherapy.
The Journal of the American Medical Association (JAMA) published a 10 year patient follow-up to a phase III clinical study on soft tissue sarcoma. Patients who received chemotherapy plus hyperthermia had an increased survival rate of 15.4 years, compared with 6.2 years for those who received neoadjuvant chemotherapy alone. Hyperthermia can be used for tumors, parts of the body or whole body.
The types of cancers we most commonly treat with hyperthermia include: